1. Introduction

Antibiotic-resistant microbe governance refers to the legal, regulatory, scientific and institutional framework used to prevent, monitor, control and respond to microorganisms that no longer respond effectively to antibiotics. The wider term is antimicrobial resistance (AMR), which also includes resistance to antivirals, antifungals and antiparasitic medicines.

Antibiotic resistance is not merely a medical problem. It raises questions of public health, environmental protection, pharmaceutical regulation, agricultural practices, hospital accountability, international cooperation and constitutional rights.

For example, if a hospital allows resistant bacteria to spread because of inadequate infection control, a pharmaceutical manufacturer improperly markets antibiotics, or an industrial facility releases antibiotic residues into waterways, several different legal duties may be involved.

The central legal question is:

How should governments regulate the use of antibiotics and the spread of resistant microorganisms while protecting patients' rights, medical access, scientific research and economic activity?

The World Health Assembly adopted an updated Global Action Plan on Antimicrobial Resistance for 2026–2036 on 23 May 2026. It reinforces the One Health approach, linking human, animal, plant, food-system and environmental health.

World Health Organization

+1

2. Meaning and scope of AMR governance

Human healthcare governance

Regulates prescriptions, diagnostic testing, hospital infection prevention, antimicrobial stewardship, clinical trials and reporting of resistant infections.

Pharmaceutical governance

Covers drug approval, manufacturing quality, marketing claims, distribution, medicine safety and incentives for developing new antibiotics.

Agriculture and veterinary governance

Addresses antimicrobial use in livestock, veterinary prescriptions, food production, residues and the transmission of resistant organisms through food chains.

Environmental governance

Covers wastewater, pharmaceutical manufacturing discharges, hospital effluent, sewage treatment and environmental surveillance.

Public accountability and justice

Determines who must prevent foreseeable harm, disclose relevant information, compensate injured persons and justify regulatory decisions.

The WHO identifies inappropriate antimicrobial use in human and animal health, food production and environmental contamination as interconnected drivers of AMR.

Antimicrobial resistance

+1

3. Legal framework in India

India is a particularly relevant jurisdiction because AMR governance requires coordination between healthcare, pharmaceutical regulation, agriculture, public health and environmental authorities.

A. Constitutional provisions

Article 21 — Right to life

The Supreme Court of India has interpreted Article 21 to include important protections relating to health and medical care. This provides a constitutional foundation for claims involving unsafe healthcare, preventable infection risks and unreasonable failures in public health protection.

However, Article 21 does not automatically establish liability every time a resistant infection occurs. The claimant must establish the relevant legal failure, causation and applicable standard of liability.

Article 14 — Equality and non-arbitrariness

Government decisions concerning access to effective antibiotics, hospital safety, allocation of scarce medicines and enforcement against pharmaceutical companies must comply with applicable equality and non-arbitrariness requirements.

Article 47 — Public health

Article 47 directs the State to improve public health and nutrition and raise living standards. It is a Directive Principle of State Policy, not an independently enforceable fundamental right, but it is relevant to interpreting public health responsibilities.

Articles 48 and 48A

These provisions address agriculture and animal husbandry and environmental protection, respectively. They support a broader governance approach in which antibiotic resistance is treated as a human, animal and environmental problem.

B. Principal legislation and regulatory instruments

India's National Action Plan on AMR 2.0 was launched on 18 November 2025. It adopts a One Health approach and includes 14 key performance indicators. The plan is a policy and implementation framework; it should not be mistaken for a standalone statute creating every proposed obligation or an automatic private right to compensation.

World Health Organization

+1

4. Important case laws and judicial principles

A preliminary point is important: there is no single universally controlling judgment that comprehensively establishes all rules of antibiotic-resistant microbe governance in India. The cases below establish related principles concerning public health, medical negligence, access to treatment and environmental protection. Their application to AMR depends on the facts and the applicable legislation.

Case 1: Paschim Banga Khet Mazdoor Samity v. State of West Bengal (1996)

Supreme Court of India · (1996) 4 SCC 37

Facts: A seriously injured person was unable to obtain appropriate emergency treatment at several government hospitals.

Legal issue: Whether failure of the public healthcare system to provide timely treatment could violate the constitutional right to life.

Judgment and principle: The Supreme Court held that the State has a constitutional obligation to provide adequate medical facilities and that failure to discharge this obligation can violate Article 21. The Court directed measures to improve emergency medical services and awarded compensation.

Relevance to AMR governance:

Patients with drug-resistant infections may need rapid diagnosis, isolation, specialist care and access to effective medicines.

Public authorities must consider whether systemic failures prevent patients from receiving appropriate treatment.

Shortages of essential antibiotics, inadequate diagnostic facilities or failures in referral systems may raise constitutional concerns where the evidence establishes a breach of the applicable duty.

The decision does not specifically concern antibiotic resistance, but it provides an important constitutional foundation for public healthcare accountability.

Indian Kanoon

Case 2: Jacob Mathew v. State of Punjab (2005)

Supreme Court of India · (2005) 6 SCC 1

Facts: The case arose from allegations of medical negligence following a patient's death in a hospital where emergency oxygen equipment was reportedly unavailable in usable condition.

Legal issue: What standard must be met before a medical practitioner can face criminal liability for professional negligence?

Judgment and principle: The Supreme Court distinguished civil negligence from criminal negligence. Criminal liability requires a substantially higher degree of negligence, and a medical error or adverse outcome alone is insufficient.

The judgment explains the importance of establishing duty, breach and resulting harm, while applying the appropriate professional standard.

Relevance to AMR governance:

Suppose a hospital fails to follow reasonable infection-control procedures and a patient subsequently develops a resistant bacterial infection. Investigators would need to examine:

Whether the hospital or practitioner owed a relevant duty of care.

Whether infection-control, diagnostic or treatment standards were breached.

Whether the breach caused or materially contributed to the injury.

Whether the evidence satisfies the particular standard required for civil, disciplinary or criminal proceedings.

A resistant infection occurring during hospitalisation does not automatically prove negligence. Nor does the failure of an antibiotic necessarily establish malpractice, because resistance can develop despite appropriate treatment.

Importance: This judgment helps prevent both unjustified criminal prosecution of healthcare professionals and the assumption that every adverse medical outcome is legally excusable.

Indian Kanoon

+1

Case 3: Kusum Sharma v. Batra Hospital & Medical Research Centre (2010)

Supreme Court of India · (2010) 3 SCC 480

Facts: The case concerned allegations that medical treatment had been negligent and that the hospital and doctors were responsible for the patient's death.

Legal issue: How should courts assess professional medical negligence when there are competing clinical opinions or alternative treatment methods?

Judgment and principle: The Supreme Court reiterated that medical negligence must be assessed against the standard of a reasonably competent practitioner. A mere difference of medical opinion or the availability of an alternative treatment does not, by itself, establish negligence.

Relevance to antibiotic resistance:

A doctor should not be judged solely because a prescribed antibiotic failed. Courts may need to examine the clinical evidence available at the time, susceptibility-test results, the urgency of treatment, recognised clinical standards and whether the treatment decision was reasonable in the circumstances.

Conversely, failure to respond to clear laboratory evidence, irrational antibiotic prescribing or disregard of established infection-control precautions may be relevant evidence of a breach, if supported by expert testimony and the other requirements of liability.

Importance: The decision supports evidence-based adjudication rather than hindsight-based blame.

Indian Kanoon

+1

Case 4: Vellore Citizens’ Welfare Forum v. Union of India (1996)

Supreme Court of India · (1996) 5 SCC 647

Facts: Tanneries in Tamil Nadu discharged untreated industrial effluents, causing serious environmental pollution and damage to agricultural land and water resources.

Legal issue: Whether industrial and economic activity could continue without adequate measures to prevent environmental harm.

Judgment and principle: The Supreme Court recognised the precautionary principle and the polluter-pays principle as part of Indian environmental law.

The Court emphasised that environmental authorities must anticipate and prevent environmental degradation. Where serious or irreversible damage is threatened, scientific uncertainty cannot always justify postponing preventive action. Polluters may be required to compensate victims and pay for environmental restoration.

Indian Kanoon

+1

Relevance to AMR governance:

This case is particularly important when considering antibiotic residues and resistant microorganisms released into the environment.

For example, if a pharmaceutical manufacturing facility releases antibiotic-containing wastewater, regulators may need to assess whether the discharge creates risks of resistance development and environmental spread.

The judgment supports preventive environmental regulation, but it does not establish that every discharge of antibiotic residues automatically constitutes a violation. The applicable statutory requirements, scientific evidence and causal connection must still be assessed.

Case 5: Consumer Education and Research Centre v. Union of India (1995)

Supreme Court of India · (1995) 3 SCC 42

Legal issue: Whether protection of workers' health forms part of the constitutional right to life.

Judgment and principle: The Court recognised the right to health and medical care of workers as an integral part of Article 21, read with relevant Directive Principles of State Policy.

Relevance to AMR governance:

Healthcare workers, laboratory personnel, sanitation workers and workers handling biological materials may face occupational exposure to resistant microorganisms. Employers and relevant authorities must comply with applicable workplace safety and health obligations.

The case also supports the broader proposition that economic activity cannot simply disregard serious occupational health risks.

Indian Kanoon

5. Core legal doctrines governing antibiotic resistance

A. Precautionary principle

Authorities should adopt proportionate preventive measures when credible scientific evidence indicates a serious risk, even if every detail of the risk is not yet conclusively established.

Application: Monitoring high-risk pharmaceutical discharges, strengthening hospital infection controls and investigating unusual resistance clusters.

B. Polluter-pays principle

A polluter may be required to compensate affected persons and pay for remediation where the applicable law and evidence establish liability.

Application: Environmental damage associated with inadequately controlled industrial wastewater. Vellore Citizens’ Welfare Forum provides the relevant foundational principle.

C. Duty of care and professional negligence

Hospitals and healthcare professionals must meet the legally applicable standard of reasonable care.

Application: Failures involving infection prevention, specimen handling, diagnostic follow-up or antibiotic prescribing may give rise to liability where breach and causation are established.

D. Proportionality and access to medicine

Measures restricting inappropriate antibiotic use must be balanced with access to effective treatment when clinically necessary.

Application: Prescription controls and stewardship policies should not prevent patients from receiving urgently needed, appropriately prescribed antibiotics.

E. Transparency and accountability

Regulatory authorities should act within their legal powers, provide reasons where required, maintain appropriate records and remain subject to review.

Application: Decisions concerning drug approvals, recalls, resistance surveillance and environmental enforcement should be evidence-based and legally reviewable.

6. Governance of antibiotic use in hospitals

Hospital governance is one of the most direct ways to control the emergence and spread of resistant microorganisms.

A sound legal and institutional framework generally includes:

Antimicrobial stewardship: Policies for appropriate prescribing, review of antibiotic treatment and prevention of unnecessary or excessively broad-spectrum use.

Diagnostic stewardship: Appropriate specimen collection, microbiological testing and interpretation of susceptibility results.

Infection prevention and control: Hand hygiene, sterilisation, isolation where indicated and environmental cleaning.

Surveillance and reporting: Monitoring resistant organisms and investigating outbreaks in accordance with applicable reporting requirements.

Accountability: Documenting clinical decisions, investigating preventable infections and implementing corrective measures.

Illustrative legal scenario

A hospital repeatedly records infections involving a resistant organism. An internal investigation identifies deficiencies in sterilisation procedures, but management fails to implement corrective measures.

Potential legal consequences could include regulatory inspection, professional disciplinary proceedings, civil claims and, in sufficiently serious circumstances, criminal proceedings. Each requires its own statutory basis and proof.

By contrast, if the hospital follows reasonable infection-control procedures and the infection occurs despite appropriate precautions, the mere fact that the organism is resistant does not establish liability.

The governing distinction is between an adverse outcome and a legally attributable failure of care.

7. Pharmaceutical regulation and antibiotic development

Antibiotic governance must address both the misuse of existing medicines and the need for effective new treatments.

The Drugs and Cosmetics Act, 1940, and associated rules provide the principal statutory framework for relevant drug manufacturing, quality and sale requirements in India. Marketing authorisation and clinical-trial requirements must be assessed under the applicable rules and regulatory arrangements.

Important regulatory functions include:

Verifying the quality, safety and efficacy of antibiotic products.

Controlling misleading therapeutic claims and unlawful sale or distribution.

Monitoring adverse events and relevant safety signals.

Ensuring appropriate clinical-trial oversight.

Investigating substandard or falsified antibiotics.

Encouraging research into new antibiotics, diagnostics and alternative treatments.

A drug that is manufactured improperly or contains less active ingredient than required may fail to deliver the intended therapeutic effect. However, substandard quality and biological resistance are distinct problems and require different evidence.

Regulation should also account for the economic challenge of antibiotic development: new antibiotics need to be available when clinically necessary, but unnecessary use can undermine their long-term effectiveness.

8. Agriculture, veterinary medicine and food production

Antibiotic-resistant organisms can move between people, animals, food systems and the environment. Consequently, a governance system limited to hospitals will not address the entire problem.

Relevant regulatory measures may include:

Veterinary oversight of antimicrobial use.

Restrictions on particular uses where prescribed by law.

Monitoring antibiotic consumption in livestock.

Food-safety surveillance and appropriate testing.

Enforcement against unlawful drug residues or other regulated contamination.

Better biosecurity, sanitation and vaccination practices.

Legal restrictions must be based on the relevant legislation, regulations and authorised standards. It would be incorrect to assume that all veterinary antibiotic use is unlawful or that every agricultural use causes human infection.

The One Health approach instead requires risk assessment and coordination between human health, veterinary, food-safety and environmental authorities.

Antimicrobial resistance

+1

9. International governance and cooperation

AMR crosses national borders through travel, trade, food distribution, animal movement and environmental pathways. International cooperation is therefore essential.

The updated WHO Global Action Plan for 2026–2036 strengthens the international emphasis on surveillance, infection prevention, responsible antimicrobial use, innovation, sustainable financing and accountability.

World Health Organization

+1

These instruments differ in legal status. International policy plans and technical guidance do not automatically operate as directly enforceable domestic legislation. Their domestic effect depends on applicable constitutional rules, legislation and implementation measures.

10. Evidence, causation and litigation

AMR cases can be scientifically complex because resistant organisms may arise from several sources, and the same infection may have multiple contributing factors.

Evidence may include:

Microbiology reports and antimicrobial susceptibility testing.

Whole-genome sequencing or other molecular evidence.

Hospital infection-control records.

Prescribing and medication-administration records.

Environmental sampling and wastewater testing.

Expert epidemiological evidence.

Manufacturing records and pharmaceutical quality testing.

Genomic similarity may help identify a possible transmission link, but it does not necessarily establish the exact source, direction of transmission or legal responsibility. Courts must assess the totality of the evidence.

The applicable burden of proof depends on the type of proceeding. A civil compensation claim, professional disciplinary proceeding, environmental enforcement action and criminal prosecution do not necessarily use identical standards.

11. Major challenges in AMR governance

Fragmented responsibility: Different authorities regulate hospitals, medicines, agriculture and pollution. Weak coordination can leave gaps in prevention and enforcement.

Insufficient surveillance: Incomplete or inconsistent data can delay outbreak detection and make it difficult to evaluate whether interventions work.

Access versus conservation: Excessively restrictive controls can deny patients necessary treatment, while excessive or inappropriate use accelerates selection for resistance.

Environmental attribution: It may be difficult to identify which discharge or source contributed to resistant organisms in a river, sewage system or community.

Innovation incentives: New antibiotic development requires investment, but sales-volume incentives may conflict with stewardship objectives that discourage unnecessary use.

Unequal institutional capacity: Smaller hospitals, rural health facilities and under-resourced laboratories may need funding, training and infrastructure to meet effective prevention standards.

These challenges call for a combination of enforceable legal duties, public investment, scientific evidence and transparent institutional accountability.

12. Practical framework for evaluating a legal dispute

When examining a particular AMR dispute, the following sequence can help structure the legal analysis.

Identify the source of the risk. Determine whether the dispute concerns clinical treatment, hospital transmission, pharmaceutical quality, animal use or environmental contamination.

Identify the applicable legal duty. Locate the relevant statute, regulation, licence condition, professional standard or constitutional obligation.

Establish the scientific facts. Examine laboratory findings, surveillance data, exposure pathways and expert evidence.

Assess breach and causation. Determine whether an identifiable legal duty was breached and whether the evidence connects that breach to the harm alleged.

Determine the appropriate remedy. Possible outcomes include corrective directions, regulatory penalties, professional discipline, environmental remediation, compensation or criminal proceedings where legally justified.

13. Conclusion

Antibiotic-resistant microbe governance is a multidisciplinary legal framework concerned with protecting public health while preserving access to effective medicines. In India, its foundations include Article 21, public health obligations, drug regulation, environmental legislation and professional standards.

The principal judicial authorities discussed above perform complementary functions:

Paschim Banga Khet Mazdoor Samity — constitutional responsibility for adequate medical facilities.

Jacob Mathew — the distinction between ordinary and criminal medical negligence.

Kusum Sharma — assessment of professional negligence against reasonable medical standards.

Vellore Citizens’ Welfare Forum — precautionary action and polluter-pays principles in environmental law.

Consumer Education and Research Centre — the constitutional importance of worker health and medical care.

The central legal principle is that AMR governance requires prevention, evidence-based regulation, access to appropriate treatment and accountable decision-making across human, animal and environmental health. The cited cases provide relevant legal foundations; they should not be represented as direct judicial rulings on every aspect of antibiotic resistance.

For further research, the most important next step is to examine the precise statutory duty and evidence involved in the particular dispute, rather than treating antibiotic resistance itself as automatic proof of legal liability.